Literature DB >> 8352256

Gentamicin clearance during hemodialysis: a comparison of high-efficiency cuprammonium rayon and conventional cellulose ester hemodialyzers.

R Agarwal1, R D Toto.   

Abstract

The advent of high-efficiency hemodialyzers has afforded improved efficiency of urea clearance; however, increased clearance of other substances, particularly antibiotics, also may occur, necessitating changes in clinical practice. Accordingly, we compared the efficiency of gentamicin removal using two different hemodialyzers, a conventional saponified cellulose ester (CD 135) and a high-efficiency cuprammonium rayon dialyzer (TAF 175L), in eight hospitalized patients undergoing antibiotic therapy for suspected or proven gram-negative infection. The rate of dialysis, estimated as the ratio of dialyzer urea clearance (K) to urea distribution volume (V) (K/V urea), and the total elimination rate constant (k) of gentamicin were measured during 17 hemodialysis treatments. The K/V urea for the two dialyzers, TAF 175L and CD 135, was 0.390 +/- 0.024 hr-1 and 0.413 +/- 0.129 hr-1 (P = NS), respectively. The TAF 175L hemodialyzer was almost twice as efficient in removing gentamicin as the CD 135: TAF 175, k = 0.263 +/- 0.024 hr-1; CD 135, k = 0.132 +/- 0.027 hr-1 (P < 0.001). Moreover, the rate of dialysis (K/V urea) was correlated with k of gentamicin for the TAF 175L dialyzer (r2 = 0.50, P < 0.02) but not for the CD 135 dialyzer. We conclude that dialyzer characteristics and the rate of dialysis (K/V urea) should be taken into consideration when determining the dosage of gentamicin in patients on hemodialysis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8352256     DOI: 10.1016/s0272-6386(12)70321-9

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  5 in total

Review 1.  Antibiotic dosing in critically ill patients with acute kidney injury.

Authors:  Rachel F Eyler; Bruce A Mueller
Journal:  Nat Rev Nephrol       Date:  2011-02-22       Impact factor: 28.314

2.  Administration of aminoglycosides to hemodialysis patients immediately before dialysis: a new dosing modality.

Authors:  H Matsuo; J Hayashi; K Ono; K Andoh; Y Andoh; Y Sano; K Saruki; J Tanaka; M Yamashita; K Nakamura; K Kubo
Journal:  Antimicrob Agents Chemother       Date:  1997-12       Impact factor: 5.191

3.  Pharmacokinetics of gentamicin in hemodialysis patients: a comparative study between diabetic and non-diabetic patients.

Authors:  Mohammed A Al-Homrany; Yacoub M Irshaid; Assem K El Sherif; Haider A Omar
Journal:  Int Urol Nephrol       Date:  2008-09-03       Impact factor: 2.370

4.  Influence of hemodialysis on gentamicin pharmacokinetics, removal during hemodialysis, and recommended dosing.

Authors:  Kevin M Sowinski; Stephanie J Magner; Aroonrut Lucksiri; Meri K Scott; Richard J Hamburger; Bruce A Mueller
Journal:  Clin J Am Soc Nephrol       Date:  2008-01-30       Impact factor: 8.237

5.  Bayesian pharmacokinetics of gentamicin in a haemodialysis population.

Authors:  Lavern M Vercaigne; Robert E Ariano; James M Zacharias
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.